Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1Gynecologic 1Genitourinary 1Classical hematology 1CNS 1Breast 1

Conditions

Ovarian Neoplasms 1

Interventions

olaparib 6Specimen Handling 5Paclitaxel 5Magnetic Resonance Spectroscopy 5Cyclophosphamide 4Carboplatin 4pembrolizumab 3fludarabine 3X-Rays 3Taxes 3Metformin 3Letrozole 3Fluorodeoxyglucose F18 3Biopsy 3Aspirin 3niraparib 2Tirzepatide 2Radiotherapy 2Propranolol 2Platinum 2Pafolacianine 2Oncolytic Virotherapy 2Hysterectomy 2Hyperthermic Intraperitoneal Chemotherapy 2Fluorescein 2Drug Therapy 2Doxorubicin 2Cytoreduction Surgical Procedures 2Cisplatin 21,2-diaminocyclohexaneplatinum II citrate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Simvastatin × Gynecologic × Clear all
NCT04457089 2026-02-04

Statin Therapy to Reduce Progression in Women With Platinum Sensitive Ovarian Cancer

Cedars-Sinai Medical Center

Phase EARLY_PHASE1 Completed
18 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡